Paid Clinical Trials in Conroe, TX
As of July 2026, 41 paid clinical trials are recruiting in Conroe, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Conroe offers studies at sites including MD Anderson in The Woodlands for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Metastatic Malignant Neoplasm in the Brain, Metastatic Renal Cell Carcinoma, Obesity. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Conroe
Trials by drug in Conroe
Filter results
Newly added in Conroe
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
40 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Wellness of Osteopathic Medical Students Throughout Their Training (Well-COM)
ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
Top Research Study Locations in Conroe
Researchers run research studies in Conroe, TX at 19 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MD Anderson in The Woodlands | Metastatic Malignant Neoplasm in the Brain, Stage IV Lung Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 | 14 |
| UT MD Anderson - The Woodlands | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 9 |
| Sam Houston State University College of Osteopathic Medicine | Students, Medical, Type 2 Diabetes | 2 |
| The University of Texas MD Anderson Cancer Center - Conroe | Advanced Breast Cancer, Advanced Non-Small Cell Lung Cancer, Advanced/Metastatic Solid Tumors | 2 |
| The University of Texas, MD Anderson Cancer Center - Woodlands | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 2 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| GSK Investigational Site | Bronchiectasis | 1 |
| Javara - Privia Medical Group Gulf Coast - The Woodlands HWH | Coronavirus Disease (COVID-19) | 1 |
| Javara Inc. / Privia Medical Group Gulf Coast PLLC | Heart Failure, Obesity | 1 |
| Javara Research | Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Obesity | 1 |
| Javara inc. | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 1 |
| Legent Institute of Specialized Surgery | Lumbar Spinal Stenosis | 1 |
| MD Anderson The Woodlands | Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer | 1 |
| Mem Hermann Surg Ctr Conroe | Lumbar Spinal Stenosis | 1 |
| North Pines Surgery Center | Lumbar Spinal Stenosis | 1 |
| SHSU College of Osteopathic Medicine | Hyperglycaemia (Non Diabetic), Pre Diabetic | 1 |
| SHSU Physician's Clinic | Hyperglycaemia (Non Diabetic), Pre Diabetic | 1 |
| The University of Texas, MD Anderson Cancer Center - Conroe | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, Renal Cell | 1 |
| VIP Surgical Center | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Conroe (2026)
Recruiting trials in Conroe grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (27 active studies)
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer · Phase 1, Phase 2 · Pfizer
- A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors · Phase 1 · Pfizer
Diabetes & metabolic (3 active studies)
Cardiovascular (3 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Vaccines (2 active studies)
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) · Phase 3 · Merck Sharp & Dohme LLC
- Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery · M.D. Anderson Cancer Center
Eye & vision (1 active study)
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Common conditions studied in Conroe
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Metastatic Malignant Neoplasm in the Brain (2 active studies)
- Metastatic Renal Cell Carcinoma (2 active studies)
- Obesity (2 active studies)
- Stage IV Lung Cancer AJCC v8 (2 active studies)
- Stage IVA Prostate Cancer AJCC v8 (2 active studies)
Leading research sponsors in Conroe
- NRG Oncology
- Pfizer
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Sam Houston State University
Frequently asked questions
How many paid clinical trials are currently recruiting in Conroe?
There are approximately 41 recruiting clinical trials in Conroe, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Conroe pay participants?
Most recruiting trials in Conroe compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Conroe?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Conroe?
The most common conditions under active study in Conroe include Anatomic Stage II Breast Cancer AJCC v8 (3), Metastatic Malignant Neoplasm in the Brain (2), Metastatic Renal Cell Carcinoma (2), Obesity (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Conroe?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Conroe on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Conroe?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Conroe?
Recruiting research sites in Conroe include MD Anderson in The Woodlands, UT MD Anderson - The Woodlands, Sam Houston State University College of Osteopathic Medicine, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Conroe right now?
The largest active categories in Conroe are Cancer & tumors (27), Diabetes & metabolic (3), Cardiovascular (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.